Literature DB >> 23537914

Viral-associated lymphoid proliferations.

Stefania Pittaluga1.   

Abstract

The histological spectrum of viral-associated lymphoid proliferations is quite broad, ranging from reactive lymphadenitis to atypical proliferations mimicking classical Hodgkin lymphoma or non-Hodgkin lymphoma. Virally associated reactive lesions can appear quite alarming on histological examination, because of direct (cytopathic) and indirect viral-induced changes eliciting a polymorphic cellular host response. In addition, the atypical lymphoid proliferation may show aberrant phenotypic features as well as restricted/clonal gene immunoglobulin or T-cell receptor rearrangements, further complicating the interpretation. In order to achieve an accurate diagnosis, it is important to be aware of the clinical history, including family history and ethnic background, clinical presentation, symptoms, and extent of the disease. Among the clinical data, particular emphasis should be placed on serology and viral load studies, and the use of immunosuppressive drugs. The clinical course and outcome vary greatly, from an indolent, self-limited to aggressive clinical course, blurring at times the distinction between neoplastic and reactive proliferations. It is now recognized that immunosenescence also plays a significant role in the development of these viral-associated lymphoid proliferations, and new entities have been described in recent years. In this review we discuss mostly Epstein-Barr virus-associated viral proliferations that may be confused with lymphomas, which the practicing pathologist may encounter. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23537914      PMCID: PMC3686967          DOI: 10.1053/j.semdp.2012.08.009

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  30 in total

1.  Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue.

Authors:  G Niedobitek; H Herbst; L S Young; L Brooks; M G Masucci; J Crocker; A B Rickinson; H Stein
Journal:  Blood       Date:  1992-05-15       Impact factor: 22.113

2.  Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils.

Authors:  S David Hudnall; Yimin Ge; Longxing Wei; Ning-Ping Yang; Hui-Quin Wang; Tiansheng Chen
Journal:  Mod Pathol       Date:  2005-04       Impact factor: 7.842

Review 3.  Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?

Authors:  Hiroshi Kimura
Journal:  Rev Med Virol       Date:  2006 Jul-Aug       Impact factor: 6.989

Review 4.  The chronic mononucleosis syndrome.

Authors:  S E Straus
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226

5.  Large clonal expansions of CD8+ T cells in acute infectious mononucleosis.

Authors:  M F Callan; N Steven; P Krausa; J D Wilson; P A Moss; G M Gillespie; J I Bell; A B Rickinson; A J McMichael
Journal:  Nat Med       Date:  1996-08       Impact factor: 53.440

6.  Human herpesvirus-6-associated acute lymphadenitis in immunocompetent adults.

Authors:  Irina Maric; Ron Bryant; Mones Abu-Asab; Jeffrey I Cohen; Angelica Vivero; Elaine S Jaffe; Mark Raffeld; Maria Tsokos; Peter M Banks; Stefania Pittaluga
Journal:  Mod Pathol       Date:  2004-11       Impact factor: 7.842

7.  Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients.

Authors:  Naoko Asano; Kazuhito Yamamoto; Jun-Ichi Tamaru; Takashi Oyama; Fumihiro Ishida; Koichi Ohshima; Tadashi Yoshino; Naoya Nakamura; Shigeo Mori; Osamu Yoshie; Yoshie Shimoyama; Yasuo Morishima; Tomohiro Kinoshita; Shigeo Nakamura
Journal:  Blood       Date:  2008-12-15       Impact factor: 22.113

8.  Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008.

Authors:  J I Cohen; H Kimura; S Nakamura; Y-H Ko; E S Jaffe
Journal:  Ann Oncol       Date:  2009-06-10       Impact factor: 32.976

9.  Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients.

Authors:  Takashi Oyama; Kazuhito Yamamoto; Naoko Asano; Aya Oshiro; Ritsuro Suzuki; Yoshitoyo Kagami; Yasuo Morishima; Kengo Takeuchi; Toshiyuki Izumo; Shigeo Mori; Koichi Ohshima; Junji Suzumiya; Naoya Nakamura; Masafumi Abe; Koichi Ichimura; Yumiko Sato; Tadashi Yoshino; Tomoki Naoe; Yoshie Shimoyama; Yoshikazu Kamiya; Tomohiro Kinoshita; Shigeo Nakamura
Journal:  Clin Cancer Res       Date:  2007-09-01       Impact factor: 12.531

Review 10.  Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.

Authors:  Koichi Ohshima; Hiroshi Kimura; Tadashi Yoshino; Chul Woo Kim; Young H Ko; Seung-Suk Lee; Suat-Cheng Peh; John K C Chan
Journal:  Pathol Int       Date:  2008-04       Impact factor: 2.534

View more
  2 in total

Review 1.  Early lymphoid lesions: conceptual, diagnostic and clinical challenges.

Authors:  Karthik A Ganapathi; Stefania Pittaluga; Oreofe O Odejide; Arnold S Freedman; Elaine S Jaffe
Journal:  Haematologica       Date:  2014-09       Impact factor: 9.941

Review 2.  Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders.

Authors:  Qingqing Cai; Kailin Chen; Ken H Young
Journal:  Exp Mol Med       Date:  2015-01-23       Impact factor: 8.718

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.